Home Cart 0 Sign in  
X

[ CAS No. 141452-01-9 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 141452-01-9
Chemical Structure| 141452-01-9
Chemical Structure| 141452-01-9
Structure of 141452-01-9 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 141452-01-9 ]

Related Doc. of [ 141452-01-9 ]

Alternatived Products of [ 141452-01-9 ]

Product Details of [ 141452-01-9 ]

CAS No. :141452-01-9 MDL No. :MFCD07371630
Formula : C10H11NO2 Boiling Point : -
Linear Structure Formula :- InChI Key :VVAPQJBMJBCZMH-UHFFFAOYSA-N
M.W : 177.20 Pubchem ID :21782110
Synonyms :

Calculated chemistry of [ 141452-01-9 ]

Physicochemical Properties

Num. heavy atoms : 13
Num. arom. heavy atoms : 6
Fraction Csp3 : 0.3
Num. rotatable bonds : 2
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 52.81
TPSA : 38.33 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.9 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.04
Log Po/w (XLOGP3) : 2.09
Log Po/w (WLOGP) : 0.87
Log Po/w (MLOGP) : 1.55
Log Po/w (SILICOS-IT) : 2.0
Consensus Log Po/w : 1.71

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.46
Solubility : 0.608 mg/ml ; 0.00343 mol/l
Class : Soluble
Log S (Ali) : -2.52
Solubility : 0.529 mg/ml ; 0.00299 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.07
Solubility : 0.149 mg/ml ; 0.000843 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.59

Safety of [ 141452-01-9 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H332-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 141452-01-9 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 141452-01-9 ]
  • Downstream synthetic route of [ 141452-01-9 ]

[ 141452-01-9 ] Synthesis Path-Upstream   1~6

  • 1
  • [ 141452-01-9 ]
  • [ 15861-30-0 ]
Reference: [1] Journal of Medicinal Chemistry, 2006, vol. 49, # 14, p. 4425 - 4436
[2] Patent: CN108276382, 2018, A, . Location in patent: Paragraph 0369; 0371; 0372; 0373
  • 2
  • [ 1011-65-0 ]
  • [ 141452-01-9 ]
YieldReaction ConditionsOperation in experiment
99% at 0 - 20℃; for 1.08333 h; To a solution of lH-Indole-5-carboxylic acid methyl ester (1 g, 5.71 mmol) in 10 mL of acetic acid at 0 0C, was added sodium cyanoborohydride (1.08 g, 17.18 mmol) over 5 minutes. The mixture was stirred at room temperature for Ih. Water (3 mL) was added and all the solvents were removed under vacuum. The residue was dissolved in ethyl acetate (150 mL) and saturated NaHCCh (150 mL). The layers were separated and the aqueous layer was extracted with ethyl acetate (3 x 75 mL). The combined extracts were washed with brine (150 mL), dried, filtered and evaporated. The residue was purified by flash chromatography (0-50percent ethyl acetate in hexane + 0.1percent triethylamine) to afford 0.99 g (99percent) of 19a.
92% at 0 - 20℃; for 2 h; To a solution of 16 (0.30 g, 1.71 mmol) in AcOH (2 mL) was added sodium cyanoborohydride (0.16 g, 2.57 mmol) at 0° C., and allowed to stir at room temperature for 2 h.
The reaction was quenched with water at 0° C., concentrated NaOH was added up to pH 10.
The aqueous layer was extracted with CH2Cl2 (15 mL*3).
The combined organic layer was dried over anhydrous MgSO4 and purified by chromatography over silica gel to afford 17 as a yellow solid (92percent yield; 1:2 EtOAc/n-hexane): 1H NMR (500 MHz, CDCl3) δ 3.06 (t, J=8.5 Hz, 2H), 3.65 (t, J=8.5 Hz, 2H), 3.84 (s, 3H), 6.54 (dd, J=8.6, 4.7 Hz, 1H), 7.75-7.76 (m, 2H).
80%
Stage #1: With sodium cyanoborohydride In acetic acid at 0 - 20℃; for 1 h;
Stage #2: With water In acetic acid
Step 1: Methyl 2, 3-Dihydro-lH-indole-5-carboxylate (20);. [0192] To a cold solution of methyl indole-5-carboxylate (2 g, 11.4 mmol) in glacial acetic acid at 0°C (15 ml) sodium cyanoborohydride (1.075 g, 17.1 MMOL) was slowly added. The mixture was allowed to warm-up and stirred at room temperature for one more hour, cooled again to 0°C and quenched with H20. The pH of the resultant solution was adjusted to the value of 12 by adding aqueous NAOH, extracted with DCM, washed with brine and dried over MGS04. The dried extract was concentrated in vacuum and purified by flash chromatography (eluent 30percent EtOAc in hexane) to give the title compound 20 (1.62 g, 80percent) as a beige SOLID. 1H-NMR (DMSO) 8 : 2.94 (t, J = 8. 6 Hz, 2H); 3.51 (dt, J = 1.2, 8.6 Hz, 2H); 3.71 (s, 3H); 6.42 (d, J = 8.0 Hz, 2H); 7.54 (m, 2H).
68% With sodium cyanoborohydride In acetic acid at 20℃; for 1 h; Cooling with ice Preparation of Compound 28,4 methyl indoline-5-carboxylate
[0043] A mixture of methyl indole-5-carboxylate (0.500 g, 2.85 mmol) in AcOH (5 mL) was warmed to dissolve all solid. The solution was then cooled in an ice bath, and sodium cyanoborohydride (0.538 g, 8.56 mmol) was added portionwise over 10 min. Note that upon addition, the solution froze, thus was warmed a bit in order to achieve stirring, and occasionally cooled during the addition. After the addition was complete, the reaction mixture was allowed to warm to rt, and stirred for 1 hr. Water (1 .5 mL) was added, and the reaction mixture was concentrated to leave a viscous oil. EtOAc was added, washed with saturated NaHC03(aq) (2x). The aqueous phase was extracted with EtOAc (2x). The combined organic phases were washed with brine (1 x), dried (MgS04), filtered and concentrated. The crude material was purified by silica gel columnchromatography using 1 :1 PE to afford the title compound (344 mg, 68percent) as a white solid. 1H NMR (500 MHz, CDCI3) δ 7.77-7.74 (m, 2H), 6.55 (d, J = 8.6 Hz, 1 H), 4.1 1 (br s, 1 H), 3.84 (s, 3H), 3.65 (t, J = 8.5 Hz, 2H), 3.06 (t, J = 8.5 Hz, 2H). HRMS (ESI+): calcd for C10H12NO2 (M + H)+, 178.0863; found 178.0865.
65%
Stage #1: for 1 h;
Intermediate 5: 2,3-Dihydro-lH-indole-5-carboxylic acid methyl ester Methyl indole-5-carboxylate (1 g, 11.4 mmol) dissolved in glacial acetic acid (10 mL) was stirred at room temperature for 10 minutes. To this sodium cyanoborohydride (1.8 g, 28 mmol) was added slowly and the stirring continued for 1 hour. On completion of reaction, it was quenched by the addition of saturated sodium bicarbonate solution (150 mL) and extracted with ethyl acetate (2 x 100 mL). The organic layer was separated, dried over anhydrous Na2S04 and concentrated under reduced pressure to get the title product (0.65 g, Yield 65percent). NMR (DMSO-d6) 6(ppm): 3.23 (2H, t, -CH2), 3.61 (2H, t, -CH2), 4.0 (3H, s, -OCH3), 6.8 (1H, d, Ar-H), 7.6-7.65 (2H, m, Ar-H), 8.45 (1H, brs, -NH); MS m/z: 178.1 (M+l).

Reference: [1] Patent: WO2010/149685, 2010, A1, . Location in patent: Page/Page column 51
[2] Bioorganic and Medicinal Chemistry Letters, 2008, vol. 18, # 20, p. 5684 - 5688
[3] Patent: US2015/368195, 2015, A1, . Location in patent: Paragraph 0072
[4] Organic and Biomolecular Chemistry, 2014, vol. 12, # 44, p. 8966 - 8976
[5] Journal of Medicinal Chemistry, 2006, vol. 49, # 14, p. 4425 - 4436
[6] Organic Letters, 2011, vol. 13, # 19, p. 5124 - 5127
[7] Patent: WO2005/30704, 2005, A1, . Location in patent: Page/Page column 144
[8] Patent: WO2015/49535, 2015, A1, . Location in patent: Paragraph 0043
[9] Patent: WO2012/117421, 2012, A1, . Location in patent: Page/Page column 41-42
[10] Patent: US2011/245315, 2011, A1, . Location in patent: Page/Page column 10
[11] Patent: US2012/101081, 2012, A1, . Location in patent: Page/Page column 54; 55
[12] Organic and Biomolecular Chemistry, 2013, vol. 11, # 7, p. 1209 - 1215
[13] Journal of Organic Chemistry, 2016, vol. 81, # 2, p. 396 - 403
[14] Chemical Communications, 2018, vol. 54, # 20, p. 2494 - 2497
  • 3
  • [ 7664-93-9 ]
  • [ 1011-65-0 ]
  • [ 141452-01-9 ]
Reference: [1] Patent: US5185361, 1993, A,
  • 4
  • [ 153497-12-2 ]
  • [ 141452-01-9 ]
Reference: [1] Journal of Heterocyclic Chemistry, 1993, vol. 30, # 4, p. 1133 - 1136
  • 5
  • [ 16078-30-1 ]
  • [ 141452-01-9 ]
Reference: [1] Journal of Heterocyclic Chemistry, 1993, vol. 30, # 4, p. 1133 - 1136
  • 6
  • [ 153247-93-9 ]
  • [ 141452-01-9 ]
Reference: [1] Journal of Heterocyclic Chemistry, 1993, vol. 30, # 4, p. 1133 - 1136
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 141452-01-9 ]

Esters

Chemical Structure| 26000-33-9

[ 26000-33-9 ]

Methyl 9H-carbazole-2-carboxylate

Similarity: 0.97

Chemical Structure| 341988-36-1

[ 341988-36-1 ]

Methyl indoline-6-carboxylate

Similarity: 0.91

Chemical Structure| 177478-49-8

[ 177478-49-8 ]

Methyl 1,2,3,4-tetrahydroquinoline-6-carboxylate

Similarity: 0.89

Chemical Structure| 35708-19-1

[ 35708-19-1 ]

2-Anilinobenzoic acid methyl ester

Similarity: 0.89

Chemical Structure| 350683-40-8

[ 350683-40-8 ]

Ethyl indoline-6-carboxylate

Similarity: 0.88

Related Parent Nucleus of
[ 141452-01-9 ]

Indolines

Chemical Structure| 341988-36-1

[ 341988-36-1 ]

Methyl indoline-6-carboxylate

Similarity: 0.91

Chemical Structure| 350683-40-8

[ 350683-40-8 ]

Ethyl indoline-6-carboxylate

Similarity: 0.88

Chemical Structure| 15861-30-0

[ 15861-30-0 ]

Indoline-5-carboxylic acid

Similarity: 0.83

Chemical Structure| 380427-39-4

[ 380427-39-4 ]

Methyl 2-oxoindoline-7-carboxylate

Similarity: 0.82

Chemical Structure| 14192-26-8

[ 14192-26-8 ]

Methyl 2-oxoindoline-6-carboxylate

Similarity: 0.82